Dosage prescribing and plasma oxipurinol levels in patients receiving allopurinol therapy. 1990

G M Peterson, and R R Boyle, and H W Francis, and N W Oliver, and J Paterson, and R J von Witt, and G R Taylor
School of Pharmacy, University of Tasmania, Hobart, Australia.

This study examined dosage prescribing patterns and steady-state oxipurinol plasma concentrations in 66 patients receiving chronic allopurinol therapy. Most patients (65%) were taking 300 mg allopurinol daily, although renal impairment was common. Using published guidelines, it was estimated that 35% of patients were receiving excessive dosages of allopurinol. Consequently, the plasma oxipurinol concentrations were often very high (mean (SD) was 156 (109) mumol.l-1). Accumulation of oxipurinol was inversely related to renal function. Plasma concentrations of oxipurinol and urate were not significantly related. However, most patients with oxipurinol concentrations of up to 100 mumol.l-1 had urate concentrations within the normal reference range.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010117 Oxypurinol A xanthine oxidase inhibitor. Alloxanthine,Oxipurinol
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000369 Aged, 80 and over Persons 80 years of age and older. Oldest Old
D000493 Allopurinol A XANTHINE OXIDASE inhibitor that decreases URIC ACID production. It also acts as an antimetabolite on some simpler organisms. Allohexal,Allohexan,Alloprin,Allopurin,Allorin,Allpargin,Allural,Apulonga,Apurin,Atisuril,Bleminol,Caplenal,Capurate,Cellidrin,Embarin,Foligan,Hamarin,Jenapurinol,Lopurin,Lysuron,Milurit,Milurite,Novopurol,Pan Quimica,Progout,Pureduct,Purinol,Remid,Rimapurinol,Roucol,Suspendol,Tipuric,Uribenz,Uridocid,Uripurinol,Urosin,Urtias,Xanthomax,Xanturic,Zygout,Zyloprim,Zyloric
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor

Related Publications

G M Peterson, and R R Boyle, and H W Francis, and N W Oliver, and J Paterson, and R J von Witt, and G R Taylor
December 1987, British journal of rheumatology,
G M Peterson, and R R Boyle, and H W Francis, and N W Oliver, and J Paterson, and R J von Witt, and G R Taylor
November 1983, American family physician,
G M Peterson, and R R Boyle, and H W Francis, and N W Oliver, and J Paterson, and R J von Witt, and G R Taylor
October 1988, British journal of clinical pharmacology,
G M Peterson, and R R Boyle, and H W Francis, and N W Oliver, and J Paterson, and R J von Witt, and G R Taylor
March 1977, Journal of chromatography,
G M Peterson, and R R Boyle, and H W Francis, and N W Oliver, and J Paterson, and R J von Witt, and G R Taylor
August 1995, The New Zealand medical journal,
G M Peterson, and R R Boyle, and H W Francis, and N W Oliver, and J Paterson, and R J von Witt, and G R Taylor
January 1979, Journal of chromatography,
G M Peterson, and R R Boyle, and H W Francis, and N W Oliver, and J Paterson, and R J von Witt, and G R Taylor
October 1988, British journal of clinical pharmacology,
G M Peterson, and R R Boyle, and H W Francis, and N W Oliver, and J Paterson, and R J von Witt, and G R Taylor
February 1969, The Biochemical journal,
G M Peterson, and R R Boyle, and H W Francis, and N W Oliver, and J Paterson, and R J von Witt, and G R Taylor
January 1995, The Medical journal of Australia,
G M Peterson, and R R Boyle, and H W Francis, and N W Oliver, and J Paterson, and R J von Witt, and G R Taylor
January 1979, Arzneimittel-Forschung,
Copied contents to your clipboard!